Abstract
The adipocyte-derived hormone, leptin, signals the status of body energy stores to the central nervous system to regulate appetite and energy expenditure. A specific long-form leptin receptor (LepRb), a type I cytokine receptor, mediates leptin action on LepRb-expressing neurons in the brain. Leptin binding to LepRb activates the associated Janus kinase-2 (Jak2) tyrosine kinase to promote the phosphorylation of Jak2 and three residues on LepRb; each of these sites mediates a distinct aspect of downstream LepRb signaling, with differing physiologic functions. Tyr1138 → STAT3 signaling suppresses feeding, but is not required for a number of other leptin actions. Tyr985 binds SH2-containing tyrosine phosphatase-2 and suppressor of cytokine signaling-3 and primarily mediates the attenuation of LepRb signaling in vivo. The role for Tyr1077, the major regulator of signal transducer and activator of transcription-5 (STAT5) during leptin signaling, in the physiologic response to leptin remains unclear, although the obese phenotype of animals deleted for STAT5 in the brain suggests the potential importance of this signaling pathway. Leptin also modulates a number of other signaling pathways in the brain, including PI 3-kinase, mammalian target of rapamycin and AMP-dependent protein kinase; the pathways by which leptin controls these signals remain unclear, however, and may involve some indirect mechanisms. Important issues regarding leptin action and LepRb signaling in the future include not only the more thorough analysis of intracellular signaling pathways, but the neural substrate by which leptin acts, as most major populations of LepRb neurons remain poorly studied.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM . Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549–1555.
Tierney EF, Gregg EW, Narayan KM . Leading causes of death in the United States. JAMA 2006; 295: 383.
Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF . Lifetime risk for diabetes mellitus in the United States. JAMA 2003; 290: 1884–1890.
Friedman JM, Halaas JL . Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763–770.
Elmquist JK, Coppari R, Balthasar N, Ichinose M, Lowell BB . Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J Comp Neurol 2005; 493: 63–71.
Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW . Central nervous system control of food intake and body weight. Nature 2006; 443: 289–295.
Bates SH, Myers Jr MG . The role of leptin receptor signaling in feeding and neuroendocrine function. Trends Endocrinol Metab 2003; 14: 447–452.
Elmquist JK, Maratos-Flier E, Saper CB, Flier JS . Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1998; 1: 445–449.
Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ et al. Congenital leptin deficiency is associated with severe early onset obesity in humans. Nature 1997; 387: 903–908.
Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398–401.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–295.
Farooqi IS, O'Rahilly S . Monogenic obesity in humans. Annu Rev Med 2005; 56: 443–458.
Maffei M, Stoffel M, Barone M, Moon B, Dammerman M, Ravussin E et al. Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes 1996; 45: 679–682.
Tartaglia LA . The leptin receptor. J Biol Chem 1997; 272: 6093–6096.
Chua Jr SC, Koutras IK, Han L, Liu SM, Kay J, Young SJ et al. Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts. Genomics 1997; 45: 264–270.
Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632–635.
Chua Jr SC, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (Leptin) receptor. Science 1996; 271: 994–996.
McMinn JE, Liu SM, Liu H, Dragatsis I, Dietrich P, Ludwig T et al. Neuronal deletion of Lepr elicits diabesity in mice without affecting cold tolerance or fertility. Am J Physiol Endocrinol Metab 2005; 289: E403–E411.
Covey SD, Wideman RD, McDonald C, Unniappan S, Huynh F, Asadi A et al. The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab 2006; 4: 291–302.
de Luca C, Kowalski TJ, Zhang Y, Elmquist JK, Lee C, Kilimann MW et al. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J Clin Invest 2005; 115: 3484–3493.
Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897–901.
Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P et al. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 2001; 108: 1113–1121.
Morioka T, Asilmaz E, Hu J, Dishinger JF, Kurpad AJ, Elias CF et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 2007; 117: 2860–2868.
Elmquist JK, Elias CF, Saper CB . From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999; 22: 221–232.
Elmquist JK, Bjørbaek C, Ahima RS, Flier JS, Saper CB . Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 1998; 395: 535–547.
Baskin DG, Schwartz MW, Seeley RJ, Woods SC, Porte Jr D, Breininger JF et al. Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus. J Histochem Cytochem 1999; 47: 353–362.
Leshan RL, Björnholm M, Münzberg H, Myers Jr MG . Leptin receptor signaling and action in the central nervous system. Obesity (Silver Spring) 2006; 14 (Suppl 5): 208S–212S.
Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG . Central nervous system control of food intake. Nature 2000; 404: 661–671.
Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006; 51: 801–810.
Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V et al. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 2006; 49: 191–203.
Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006; 51: 811–822.
Kloek C, Haq AK, Dunn SL, Lavery HJ, Banks AS, Myers Jr MG . Regulation of Jak kinases by intracellular leptin receptor sequences. J Biol Chem 2002; 277: 41547–41555.
Gong Y, Ishida-Takahashi R, Villanueva EC, Fingar DC, Münzberg H, Myers Jr MG . The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms. J Biol Chem 2007; 282: 31019–31027.
Banks AS, Davis SM, Bates SH, Myers Jr MG . Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 2000; 275: 14563–14572.
Bjørbaek C, Buchholz RM, Davis SM, Bates SH, Pierroz DD, Gu H et al. Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem 2001; 276: 4747–4755.
Bjorbak C, Lavery HJ, Bates SH, Olson RK, Davis SM, Flier JS et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem 2000; 275: 40649–40657.
White DW, Kuropatwinski KK, Devos R, Baumann H, Tartaglia LA . Leptin receptor (OB-R) signaling. J Biol Chem 1997; 272: 4065–4071.
Bjørbaek C, El-Haschimi K, Frantz JD, Flier JS . The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 1999; 274: 30059–30065.
Hekerman P, Zeidler J, Bamberg-Lemper S, Knobelspies H, Lavens D, Tavernier J et al. Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J 2005; 272: 109–119.
Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC et al. Hypothalamic mTOR signaling regulates food intake. Science 2006; 312: 927–930.
Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004; 428: 569–574.
Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers Jr MG, Schwartz MW . Intracellular signaling. Key enzyme in leptin-induced anorexia. Nature 2001; 413: 794–795.
Plum L, Ma X, Hampel B, Balthasar N, Coppari R, Münzberg H et al. Enhanced PIP(3) signaling in POMC neurons causes K(ATP) channel activation and leads to diet-sensitive obesity. J Clin Invest 2006; 116: 1886–1901.
Xu AW, Kaelin CB, Takeda K, Akira S, Schwartz MW, Barsh GS . PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest 2005; 115: 951–958.
Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y et al. STAT3 signaling is required for leptin regulation of energy balance but not reproduction. Nature 2003; 421: 856–859.
Björnholm M, Münzberg H, Leshan RL, Villanueva EC, Bates SH, Louis GW et al. Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. J Clin Invest 2007; 117: 1354–1360.
Bates SH, Dundon TA, Seifert M, Carlson M, Maratos-Flier E, Myers Jr MG et al. LRb-STAT3 signaling is required for the neuroendocrine regulation of energy expenditure by leptin. Diabetes 2004; 53: 3067–3073.
Bates SH, Kulkarni RN, Seifert M, Myers Jr MG . Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis. Cell Metab 2005; 1: 169–178.
Bodary PF, Shen Y, Ohman M, Bahrou KL, Vargas FB, Cudney SS et al. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol 2007; 27: 70–76.
Dunn SL, Björnholm M, Bates SH, Chen Z, Seifert M, Myers Jr MG . Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3. Mol Endocrinol 2005; 19: 925–938.
Gao Q, Wolfgang MJ, Neschen S, Morino K, Horvath TL, Shulman GI et al. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA 2004; 101: 4661–4666.
Gao Q, Mezei G, Nie Y, Rao Y, Choi CS, Bechmann I et al. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med 2007; 13: 89–94.
Lee JY, Muenzberg H, Gavrilova O, Reed JA, Berryman D, Villanueva EC et al. Loss of Cytokine-STAT5 Signaling in the CNS and pituitary gland alters energy balance and leads to obesity. PLoS ONE 2008; 3: e1639.
Mütze J, Roth J, Gerstberger R, Hübschle T . Nuclear translocation of the transcription factor STAT5 in the rat brain after systemic leptin administration. Neurosci Lett 2007; 417: 286–291.
Miyoshi K, Cui Y, Riedlinger G, Robinson P, Lehoczky J, Zon L et al. Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse. Genomics 2001; 71: 150–155.
Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, Hissong BD et al. Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci USA 2006; 103: 1000–1005.
Fingar DC, Blenis J . Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004; 23: 3151–3171.
Inoki K, Guan KL . Complexity of the TOR signaling network. Trends Cell Biol 2006; 16: 206–212.
Jaworski J, Sheng M . The growing role of mTOR in neuronal development and plasticity. Mol Neurobiol 2006; 34: 205–219.
Nguyen PV . Protein synthesis during LTP: linking synaptic activity to translation. Trends Neurosci 2002; 25: 180.
Balthasar N, Coppari R, McMinn J, Liu SM, Lee CE, Tang V et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 2004; 42: 983–991.
Morton GJ, Niswender KD, Rhodes CJ, Myers Jr MG, Blevins JE, Baskin DG et al. Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fak/fak) rats. Endocrinology 2003; 144: 2016–2024.
van de Wall E, Leshan R, Xu AW, Balthasar N, Coppari R, Liu SM et al. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 2007; 149: 1773–1785.
Acknowledgements
This study was supported by NIH R01 DK57768 and R01DK56731 (to MGM).
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of interest
Martin G Myers has received consulting fees from BMS and lecturing fees from Merck and Amylin, as well as royalties from Millipore Inc. for the development of antibodies for research. The remaining author has declared no financial interests.
Rights and permissions
About this article
Cite this article
Villanueva, E., Myers, M. Leptin receptor signaling and the regulation of mammalian physiology. Int J Obes 32 (Suppl 7), S8–S12 (2008). https://doi.org/10.1038/ijo.2008.232
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2008.232